VivoSeq
Other

Hyperbaric Oxygen Therapy

0

Pipeline Programs

7

Active Trials

0

Companies Involved

Hyperbaric Oxygen Therapy is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

22/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

60/100

Attrition Rate

14/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

14

clinical trials

Not yet recruiting4 · 29%
Completed3 · 21%
Recruiting3 · 21%
Withdrawn2 · 14%
Unknown status2 · 14%

Trial Activity

14 trials

Barotrauma in Hyperbaric Oxygen Therapy
Recruiting·JJohn Muir Health·N/A·NCT05697328·90 enrolled
Cognitive Improvement After Carotid Stenting in Hyperbaric Oxygen Therapy Trial
Not yet recruiting··N/A·NCT05980195·90 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)